DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Takinami M, Yokota T.
Rechallenge with lenvatinib after refractoriness to initial lenvatinib followed
by sorafenib in a patient with metastatic papillary thyroid carcinoma.
Case Rep Oncol 2020;
13: 522-527
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.